Residual HIV-1 replication

被引：5

作者：

Pomerantz, RJ ^{[1
]}

机构：

[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med,Div Infect Dis, Ctr Human Virol,Dorrance H Hamilton Labs, Philadelphia, PA 19107 USA

来源：

BIOMEDICINE & PHARMACOTHERAPY | 2000年 / 54卷 / 01期

关键词：

HAART; HIV-1; latency; residual; RNA;

D O I：

10.1016/S0753-3322(00)88635-7

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：13 / 15

页数：3

共 24 条

[1] Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection [J].

Cavert, W ;

Notermans, DW ;

Staskus, K ;

Wietgrefe, SW ;

Zupancic, M ;

Gebhard, K ;

Henry, K ;

Zhang, ZQ ;

Mills, R ;

McDade, H ;

Goudsmit, J ;

Danner, SA ;

Haase, AT .

SCIENCE, 1997, 276 (5314) :960-964

[2] Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].

Chun, TW ;

Carruth, L ;

Finzi, D ;

Shen, XF ;

DiGiuseppe, JA ;

Taylor, H ;

Hermankova, M ;

Chadwick, K ;

Margolick, J ;

Quinn, TC ;

Kuo, YH ;

Brookmeyer, R ;

Zeiger, MA ;

BarditchCrovo, P ;

Siliciano, RF .

NATURE, 1997, 387 (6629) :183-188

[3] Induction of HIV-1 replication in latently infected CD4+ T cells using a combination of cytokines [J].

Chun, TW ;

Engel, D ;

Mizell, SB ;

Ehler, LA ;

Fauci, AS .

JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (01) :83-91

[4] Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].

Chun, TW ;

Stuyver, L ;

Mizell, SB ;

Ehler, LA ;

Mican, JAM ;

Baseler, M ;

Lloyd, AL ;

Nowak, MA ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197

[5] Early establishment of a pool of latently infected, resting CD4+ T cells during primary HIV-1 infection [J].

Chun, TW ;

Engel, D ;

Berrey, MM ;

Shea, T ;

Corey, L ;

Fauci, AS .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8869-8873

[6] Residual HIV-1 RNA in blood plasma of patients taking suppressive highly active antiretroviral therapy [J].

Dornadula, G ;

Zhang, H ;

VanUitert, B ;

Stern, J ;

Livornese, L ;

Ingerman, MJ ;

Witek, J ;

Kedanis, RJ ;

Natkin, J ;

DeSimone, J ;

Pomerantz, RJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (17) :1627-1632

[7] Antiretroviral drugs and the central nervous system [J].

Enting, RH ;

Hoetelmans, RMW ;

Lange, JMA ;

Burger, DM ;

Beijnen, JH ;

Portegies, P .

AIDS, 1998, 12 (15) :1941-1955

[8] Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].

Finzi, D ;

Hermankova, M ;

Pierson, T ;

Carruth, LM ;

Buck, C ;

Chaisson, RE ;

Quinn, TC ;

Chadwick, K ;

Margolick, J ;

Brookmeyer, R ;

Gallant, J ;

Markowitz, M ;

Ho, DD ;

Richman, DD ;

Siliciano, RF .

SCIENCE, 1997, 278 (5341) :1295-1300

[9] Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy [J].

Furtado, MR ;

Callaway, DS ;

Phair, JP ;

Kunstman, KJ ;

Stanton, JL ;

Macken, CA ;

Perelson, AS ;

Wolinsky, SM .

NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (21) :1614-1622

[10] Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy [J].

Gulick, RM ;

Mellors, JW ;

Havlir, D ;

Eron, JJ ;

Gonzalez, C ;

McMahon, D ;

Richman, DD ;

Valentine, FT ;

Jonas, L ;

Meibohm, A ;

Emini, EA ;

Chodakewitz, JA .

NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (11) :734-739

← 1 2 3 →